New pill hopes to slow rare brain disease MSA
NCT ID NCT06568237
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 40 times
Summary
This study tests an experimental oral drug, TEV-56286, in 350 adults with multiple system atrophy (MSA), a rare and progressive brain disorder. Participants will receive either the drug or a placebo for 48 weeks to see if it slows disease worsening and is safe. The goal is to find a treatment that helps control MSA symptoms and progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Teva Investigational Site 15543
ACTIVE_NOT_RECRUITINGSpokane, Washington, 99202, United States
-
Teva Investigational Site 15544
ACTIVE_NOT_RECRUITINGBoca Raton, Florida, 33486, United States
-
Teva Investigational Site 15545
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
-
Teva Investigational Site 15546
ACTIVE_NOT_RECRUITINGKansas City, Kansas, 66160, United States
-
Teva Investigational Site 15547
ACTIVE_NOT_RECRUITINGWashington D.C., District of Columbia, 20007, United States
-
Teva Investigational Site 15548
ACTIVE_NOT_RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
Teva Investigational Site 15549
ACTIVE_NOT_RECRUITINGNew York, New York, 10016, United States
-
Teva Investigational Site 15550
ACTIVE_NOT_RECRUITINGChicago, Illinois, 60612-3852, United States
-
Teva Investigational Site 15551
ACTIVE_NOT_RECRUITINGNew York, New York, 10032-3726, United States
-
Teva Investigational Site 15552
ACTIVE_NOT_RECRUITINGRochester, Minnesota, 55905, United States
-
Teva Investigational Site 15553
ACTIVE_NOT_RECRUITINGDurham, North Carolina, 27705-4410, United States
-
Teva Investigational Site 15554
ACTIVE_NOT_RECRUITINGLa Jolla, California, 92037, United States
-
Teva Investigational Site 15555
ACTIVE_NOT_RECRUITINGTampa, Florida, 33613, United States
-
Teva Investigational Site 15735
NOT_YET_RECRUITINGHershey, Pennsylvania, 17033, United States
-
Teva Investigational Site 15736
ACTIVE_NOT_RECRUITINGBoston, Massachusetts, 02115, United States
-
Teva Investigational Site 15869
NOT_YET_RECRUITINGGeorgetown, Texas, 78628, United States
-
Teva Investigational Site 15870
NOT_YET_RECRUITINGFarmington Hills, Michigan, 48334, United States
-
Teva Investigational Site 15873
ACTIVE_NOT_RECRUITINGAlexandria, Virginia, 22310, United States
-
Teva Investigational Site 15874
RECRUITINGNashville, Tennessee, 37212, United States
-
Teva Investigational Site 30294
ACTIVE_NOT_RECRUITINGPadova, 35127, Italy
-
Teva Investigational Site 30295
ACTIVE_NOT_RECRUITINGSalerno, 84131, Italy
-
Teva Investigational Site 30296
ACTIVE_NOT_RECRUITINGRoma, 00163, Italy
-
Teva Investigational Site 30297
ACTIVE_NOT_RECRUITINGCatania, 95123, Italy
-
Teva Investigational Site 30298
ACTIVE_NOT_RECRUITINGMilan, 20132, Italy
-
Teva Investigational Site 30299
ACTIVE_NOT_RECRUITINGBologna, 40139, Italy
-
Teva Investigational Site 31319
ACTIVE_NOT_RECRUITINGValencia, 46026, Spain
-
Teva Investigational Site 31320
ACTIVE_NOT_RECRUITINGPamplona, 31008, Spain
-
Teva Investigational Site 31321
ACTIVE_NOT_RECRUITINGBarcelona, 08036, Spain
-
Teva Investigational Site 31322
ACTIVE_NOT_RECRUITINGSeville, 41015, Spain
-
Teva Investigational Site 31323
ACTIVE_NOT_RECRUITINGBarcelona, 08035, Spain
-
Teva Investigational Site 31324
ACTIVE_NOT_RECRUITINGBarcelona, 08041, Spain
-
Teva Investigational Site 31327
ACTIVE_NOT_RECRUITINGMadrid, 28006, Spain
-
Teva Investigational Site 31328
RECRUITINGBarakaldo, 48903, Spain
-
Teva Investigational Site 31329
RECRUITINGElche, 03203, Spain
-
Teva Investigational Site 31330
RECRUITINGMadrid, 28034, Spain
-
Teva Investigational Site 31331
RECRUITINGMadrid, 28041, Spain
-
Teva Investigational Site 32818
ACTIVE_NOT_RECRUITINGDresden, 01307, Germany
-
Teva Investigational Site 32819
ACTIVE_NOT_RECRUITINGMünster, 48149, Germany
-
Teva Investigational Site 32820
ACTIVE_NOT_RECRUITINGMünchen, 81377, Germany
-
Teva Investigational Site 32821
ACTIVE_NOT_RECRUITINGUlm, 89081, Germany
-
Teva Investigational Site 32822
ACTIVE_NOT_RECRUITINGDüsseldorf, 40225, Germany
-
Teva Investigational Site 32823
ACTIVE_NOT_RECRUITINGBeelitz, 14547, Germany
-
Teva Investigational Site 32824
ACTIVE_NOT_RECRUITINGMarburg, 35033, Germany
-
Teva Investigational Site 32825
ACTIVE_NOT_RECRUITINGKassel, 34128, Germany
-
Teva Investigational Site 32826
RECRUITINGLeipzig, 04103, Germany
-
Teva Investigational Site 35289
ACTIVE_NOT_RECRUITINGMarseille, 13385, France
-
Teva Investigational Site 35290
ACTIVE_NOT_RECRUITINGBordeaux, 33400, France
-
Teva Investigational Site 35291
ACTIVE_NOT_RECRUITINGParis, 75651 Cedex 13, France
-
Teva Investigational Site 35292
ACTIVE_NOT_RECRUITINGToulouse, 31059, France
-
Teva Investigational Site 35300
RECRUITINGCaen, 14033, France
-
Teva Investigational Site 80203
ACTIVE_NOT_RECRUITINGHaifa, 31999, Israel
-
Teva Investigational Site 80204
ACTIVE_NOT_RECRUITINGTel Aviv, 6423906, Israel
-
Teva Investigational Site 80215
ACTIVE_NOT_RECRUITINGJerusalem, 9103102, Israel
-
Teva Investigational Site 84135
ACTIVE_NOT_RECRUITINGSendai, 982-8555, Japan
-
Teva Investigational Site 84136
ACTIVE_NOT_RECRUITINGGifu, 501-1112, Japan
-
Teva Investigational Site 84137
ACTIVE_NOT_RECRUITINGNiigata, 951-8520, Japan
-
Teva Investigational Site 84138
ACTIVE_NOT_RECRUITINGSagamihara, 252-0392, Japan
-
Teva Investigational Site 84139
ACTIVE_NOT_RECRUITINGFuchū, 183-0042, Japan
-
Teva Investigational Site 84140
ACTIVE_NOT_RECRUITINGChiba, 260-8677, Japan
-
Teva Investigational Site 84141
ACTIVE_NOT_RECRUITINGSanda-shi, 669-1592, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.